logo

QUEST DIAG(NYSE:DGX)
Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care.
# Employees: 42800
Address: 3 Giralda Farms,Madison,NJ,USA
Phone: 800-222-0446
Fax: 201 462-4169
Website: www.questdiagnostics.com
Email: investor@questdiagnostics.com
Sector: Medical
Industry: MED-OUTP/HM CRE
Executive Officers
Surya N. Mohapatra Ph.D. (Chmn.; Presi.; C.E.O.)
Robert A. Hagemann (Sr. V.P.; C.F.O.)
Michael E. Prevoznik (Sr. V. P. & Gen. Counsl.)
Joan E. Miller Ph.D. (Sr. V. P.; Pathology & Hospital Services)
Wayne R. Simmons (V. P.; Opera.,)
Dividend
Ex-Dividend Date: 9/30/2009
Annual Dividend: $0.40
Current Dividend Yield: $0.69
Dividend Paid (3 months): $0.10
Indicated Dividend: $0.11
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 1/25/2010
Mean EPS (Next Qtr): $0.96
Mean EPS (Year): $3.85
Mean Estimate(Long Term): $12.43
P/E Ratio(Based on EPS estimate): 15.150
Number of Estimates: 7
Shares Performance
Period DGX Compare to S&P
YTD 12.25 % -7.11 %
4 Weeks 4.18 % -1.09 %
12 Weeks 7.47 % 0.08 %
Shares Information
Analyst Coverage: Y
Avg Volume: 1037794
Shares Outstanding: 185M
Market Cap: $10.82B
52 Week High: $59.42
52 Week Low: $43.22
P/E Ratio: 15.410
PEG Ratio: 1.220
Split: On 6/21/2005 DGX split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: 2.00 %
EPS Growth in Last Year: 18.60 %
Sales Growth in Last Quarter: -0.24 %
Sales Growth in Last Quarter: 3.87 %
Financials
Qtr Book Value: $2.75
Cash Flow/Share: $12.71
Change in Payout Ratio: -0.020
Price/Sales: 1.460
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia